Home » Authors » Anette Breindl

Articles by Anette Breindl

For Cardioprotection, Akt Is Not Sole Actor, Study Finds

Nov. 30, 2007

By Anette Breindl

Non-Resveratrol Sirtuin Drugs Show Promise in Diabetes Fight

Nov. 29, 2007

By Anette Breindl

Non-Resveratrol Sirtuin Drugs Show Promise in Diabetes Fight

Nov. 29, 2007

By Anette Breindl

Noninvasive Technique Sees Adult Stem Cells In Brain

Nov. 26, 2007

By Anette Breindl

Noninvasive Technique Sees Adult Stem Cells In Brain

Nov. 26, 2007

By Anette Breindl

Two Gangs Of Four Can Induce Pluripotent State In Fibroblasts

Nov. 21, 2007

By Anette Breindl

Two Gangs Of Four Can Induce Pluripotent State In Fibroblasts

Nov. 21, 2007

By Anette Breindl

Taking Off The Brakes Turns Pro-Life Protein On Its Head

Nov. 16, 2007

By Anette Breindl

Taking Off The Brakes Turns Pro-Life Protein On Its Head

Nov. 16, 2007

By Anette Breindl

It's Real This Time: Primate ESCs Created In Laboratory

Nov. 15, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...